http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
Nonanticoagulant actions of glycosaminoglycans
Symposium on Glycosaminoglycans: Nonanticoagulant Actions of Glycosaminoglycans 1994 : Loveno, Italy)
viii, 295 pages : illustrations ; 26 cm.
Inequivalence of glycosaminoglycans using high-performance size exclusion chromataography, polyacrylamide gel electrophoresis and high performance capillary electrophoresis -- New nmr spectroscopic approaches for structural analysis of glycoasminoglycans -- Application of mass spectrometry to the analysis of natural and synthetic sulfated oligosaccharides -- Monoclonal antibody directed against heparin and heparin-fractions -- Simulation of glycosaminoglycan structures by chemical modifications of E. coli polysaccharides K5 and K4.
Pharmacology of synthetic and biotechnololgy -derived homologues and analogues of heparin -- Protein binding of sulfated glycosaminoglycans: searching for specificity -- Non-anticoagulant actions of glycosaminoglycans: protein binding studies -- Binding of glycosaminoglycans to leukocytes using fluorescent labeled GAG-derivatives -- Intact biological activity and binding to granulocytes of LMM-heparin-tyramine-fitc -- A detailed evaluation of the structural and biological effects of alkaline o-desulfation reactions of heparin.
Glycosaminoglycans and related structures as potential inhibitors for erythrocyte infection by plasmodium falciparum malaris -- The interaction of basic fibroblast growth factor (bFGF) with heparan sulfate proteoglycans: biochemical bases and biological implications -- Binding of I-bFGF to rat aortic smooth muscle cells: effect of natural and chemically modified heparins and heparan sulfates -- Modulatory role of heparin and heparan sulfates on angiogenesis -- Involvement of thrombin on GAGs release in different cellular systems.
TFPI release by GAGs and its role in their mechanism of action -- Biological activities and effects on the platelet aggregation of a structurally defined curdlan sulfate -- Influence of glycosaminoglycans on natural killer cell activity -- Non-antioagulant actions of glycosaminoglycans (GAGs): the therapeutical approach to Alzheimer's disease -- Therapy with glycosaminoglycans in nephrology.
edited by Job Harenberg and Benito Casu.
"Proceedings of the Fourth Symposium on Glycosaminoglycans: Nonanticoagulant Actions of Glycosaminoglycans--results and perspectives of the German--Italian collaboration, held October 6-8,1994, in Loveno, Italy"--Title page verso.
Includes bibliographical references and index.